6 completed, 1 recruiting. 3 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Polysaccharides: new trials by email Literature Review of Polysaccharides trials Research Report on Polysaccharides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glycan Supplementation on a Human Model of Crohn's Disease Initiation and Progression Glycan - Crohn Disease (CD) | Not applicable | Recruiting | GLSMED Learning Health S.A. | 30 | 2025-05-26 | 2026-10-15 |
| A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age Multivalent, Tdap, polysaccharide - Pneumococcal Infections | Phase 2 | Completed | Pfizer | 511 | 2017-10-12 | 2020-06-04 |
| Understanding the Immune Response to Two Different Meningitis Vaccines MenACWY-CRM conjugate vaccine (Menveo, Novartis), MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis), 1/5th dose MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis) - Meningitis, Meningococcal Disease | Phase 4 | Completed | University of Oxford | 20 | 2012-12-01 | 2026-05-04 |
| Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants Vi-CRM197 vaccine, Pneumococcal conjugate vaccine, Vi Polysaccharide (PS) vaccine - Typhoid Fever | Phase 2 | Completed | Novartis | 120 | 2011-10-01 | 2014-04-10 |
| Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants Vi-CRM197 vaccine, Vi Polysaccharide (PS) vaccine, Pneumococcal conjugate vaccine - Typhoid Fever | Phase 2 | Completed | Novartis | 200 | 2011-03-01 | 2014-05-01 |
| CVD 909 Vi Prime Boost Study CVD 909, Placebo, Vi Polysaccharide - Typhoid Fever | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 21 | 2006-02-01 | 2014-05-09 |
| The Effect of American Ginseng Root and Its Components on Glycemia in Healthy Individuals American ginseng root / polysaccharides - Hyperglycemia | Phase 3 | Completed | Risk Factor Modification Centre | 12 | 2005-06-01 | 2006-08-23 |
Typhoid Fever (3) · Crohn Disease (1) · Hyperglycemia (1) · Meningitis (1) · Meningococcal Infections (1) · Pneumococcal Infections (1) · Toxemia (1)
Novartis (2) · GLSMED Learning Health S.A. (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Pfizer (1) · Risk Factor Modification Centre (1) · University of Oxford (1)
United States (2) · Canada (1) · India (1) · Pakistan (1) · Philippines (1) · Portugal (1) · United Kingdom (1)
Andrew J Pollard, BA, MBBS, FRCPCH, PhD (1) · Maria Rosario Z Capeding, MD (1) · Vladimir Vuksan, Ph.D. (1)